MHRA Drug Safety Update July 2019
MHRA Drug Safety Update July 2019
July 18, 2019
Date issued: 17th July 2019
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 12 Issue 12 July 2019) has been published and includes articles on:
- Febuxostat (Adenuric): increased risk of cardiovascular death and all-cause mortality in clinical trial in patients with a history of major cardiovascular disease
- Tocilizumab (RoActemra): rare risk of serious liver injury including cases requiring transplantation
- Rivaroxaban (Xarelto▼): reminder that 15 mg and 20 mg tablets should be taken with food
- Letters and drug alerts sent to healthcare professionals in June 2019
- Medical Device Alerts issued in June 2019
To see the latest MHRA Drug Safety Update in full, visit the GOV.uk website.
Posted in: Dispensing & Supply
